BTRC and cancer: This is consistent with the pathology of PTEN−/−-leading cancer, in which the abnormal nuclear accumulation of Nrf2 is caused by an impairment of GSK3β- directed β-TrCP-based proteasome-mediated degradation, as described by [19,20,21].